You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 5, November 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cataracts in Patients with Rheumatic Diseases Treated with Corticosteroids

Further Observations

RICHARD B. OGLESBY, M.D.; ROGER L. BLACK, M.D.; LUDWIG von SALLMANN, M.D.; JOSEPH J. BUNIM, M.D.

Arch Ophthalmol. 1961;66(5):625-630.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A previous communication by the authors related the development of posterior subcapsular cataracts (PSC) to long-term high dose corticosteroid therapy,1 and a subsequent paper2 discussed the appearance and differential diagnosis of these cataracts. This report includes additional patients with the same complication and follow-up data on patients previously and presently reported.

Methods and Material

Collection of data and examination were carried out as outlined in previous papers. The diagnosis was established in all cases by biomicroscopy; patients with other ocular pathology which might be related to PSC were omitted from the series.

This series consists of 95 patients. Twentythree of these had rheumatoid arthritis not treated with corticosteroids and thus served as controls; none of the controls developed PSC. Seventy-two patients, 28 of whom have not been reported previously, were treated with corticosteroids; of these 72 patients, 30 developed PSC (Table 2). Medical diagnoses of the corticosteroid treated . . . [Full Text PDF of this Article]


Author Affiliations

Bethesda, Md.

From the Ophthalmology Branch (Drs. Oglesby and von Sallmann), National Institute of Neurological Diseases and Blindness and the Arthritis and Rheumatism Branch, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, U.S. Public Health Service, U.S. Department of Health, Education and Welfare.


Footnotes

Submitted for publication July 10, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.